Now FDA approved for cervical dystonia
DAXXIFY® is the first new botulinum toxin to be approved for cervical dystonia in adults in over 10 years, featuring proven, long-lasting symptom relief.*
Stay Updated On Product Availability Read Press Release *Median duration of effect, defined as time from treatment until loss of ≥80% of the peak effect (change from baseline in TWSTRS total score averaged across weeks 4 and 6), was 24 weeks with DAXXIFY® 125U and 20.3 weeks with DAXXIFY® 250U. In patients that requested retreatment prior to the loss of > 80% of peak effect, median efficacy remaining was 45% to 54% in ASPEN-1. Median time to retreatment was between 16 and 17 weeks in ASPEN-1 and cycles 1 and 2 in the ASPEN OLS.What is cervical dystonia?
A painful and often debilitating condition
With cervical dystonia, the neck muscles contract involuntarily, causing abnormal movements and awkward posture of the head and neck.
Proven to deliver long-lasting symptom relief
- - In a large clinical trial, DAXXIFY® treatment effect lasted longer than the traditional 12-week injection cycle for most people*
- - Formulated with a proprietary peptide and no animal byproducts
- - Low rate of adverse events (side effects)†
True innovation for the treatment of cervical dystonia
Hear from experts about the challenges of cervical dystonia
Dr. Joseph Jankiovic
Professor of Neurology, Distinguished Chair of Movement Disorders
Janet Hieshetter
Executive Director, Dystonia Medical Research Foundation
Advocacy groups can provide additional information, support, and resources.
Connect with organizations using these links:
The benefits of the DAXXIFY® Patient Savings Program*
For eligible commercially insured patients, the DAXXIFY® Patient Saving Program can help with eligible, out-of-pocket costs associated with DAXXIFY® treatments.
• Pay as little as $0 for your DAXXIFY® treatment
• Save up to $5,000 per year on out-of-pocket costs for eligible DAXXIFY® treatments
*Terms and conditions may apply. Not a guarantee of coverage.Download, complete and fax the form below to 1-855-FAX-DAXI (1-855-329-3294).
Download Form